Ozempic (semaglutide) and Victoza (liraglutide) are prescription drugs used to treat type 2 diabetes and reduce the risk of cardiovascular problems. Both drugs come as an injection. Ozempic and ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market. The drug, liraglutide, is sold under the brand names Victoza and Saxenda. Patents for Victoza ...

The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

If you plan to become pregnant in the near future, your provider may switch you to a different GLP-1 such as liraglutide (Saxenda or Victoza). You take liraglutide daily, vs. weekly for Ozempic ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Specifically, the CWR team looked at three years of healthcare data for folks who had just begun taking diabetes drugs like ...

The drugs affected by the new warning include: Semaglutide, with brand names Ozempic, Rybelsus, and Wegovy Liraglutide, which ...